Corcept Therapeutics Incorporated (CORT) Financials

CORT Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 888.7 million 182.9 million
March 31, 2026 814.9 million 176.9 million
Dec. 31, 2025 836.7 million 188.8 million
Sept. 30, 2025 823.6 million 191.7 million

CORT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 31.0 million 29.4 million
March 31, 2026 -17.0 million 23.0 million
Dec. 31, 2025 38.4 million -63.7 million
Sept. 30, 2025 54.5 million 22.9 million

CORT Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 43.0 million
March 31, 2026 -31.8 million
Dec. 31, 2025 98.2 million
Sept. 30, 2025 19.4 million

CORT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 308.2 million 7.5 million 9.4 million
March 31, 2026 338.2 million 8.0 million 1.6 million
Dec. 31, 2025 372.2 million 5.0 million 1.1 million
Sept. 30, 2025 421.7 million - 5.3 million

CORT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 118.4 million
March 31, 2026 104.4 million
Dec. 31, 2025 119.9 million
Sept. 30, 2025 119.4 million

CORT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 2.5 million 53.9 million 156.9 million -
March 31, 2026 201000 66.3 million 145.4 million -
Dec. 31, 2025 50000 64.9 million 130.2 million -
Sept. 30, 2025 - 68.8 million 124.0 million -

CORT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 256.1 million 4.1 million
March 31, 2026 164.9 million 2.9 million
Dec. 31, 2025 202.1 million 2.5 million
Sept. 30, 2025 207.6 million 4.6 million

CORT

Price: $114.47

52 week price:
28.66
122.21

Earnings Per Share: 0.44 USD

P/E Ratio: 249.55

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 611800

Ebitda: 13.7 million

Market Capitalization: 12.0 billion

Links: